Pharmacokinetics of buflomedil after intravenous and oral administration. 1980

E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive

Pharmacokinetics studies were conducted in 4 patients who received buflomedil 100 mg intravenously and in 3 volunteers who received buflomedil 450 mg per os. Buflomedil concentrations were determined by a gas liquid chromatography method. Buflomedil levels declined multiphasically with a mean clearance after intravenous administration of -0,034 (1 h-1 kg-1). The decline appeared to be monophasic after oral administration. In both cases the overall half-life is short, mean 2.07 hrs (range, 1,47-2,6 hrs).

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002090 Butyrophenones Compounds containing phenyl-1-butanone.
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
January 1981, European journal of clinical pharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
December 1984, International journal of clinical pharmacology, therapy, and toxicology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
March 1989, British journal of clinical pharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
September 1983, The Journal of antimicrobial chemotherapy,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
November 1982, International journal of clinical pharmacology, therapy, and toxicology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
January 1983, European journal of clinical pharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
January 1983, Cancer chemotherapy and pharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
March 1981, European journal of clinical pharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
August 1995, Journal of clinical psychopharmacology,
E Rey, and G Barrier, and P d'Athis, and D de Lauture, and M O Richard, and J P Lirzin, and C Sureau, and G Olive
January 1983, Clinical pharmacokinetics,
Copied contents to your clipboard!